Luu Hue H, Song Wen-Xin, Luo Xiaoji, Manning David, Luo Jinyong, Deng Zhong-Liang, Sharff Katie A, Montag Anthony G, Haydon Rex C, He Tong-Chuan
Molecular Oncology Laboratory, Department of Surgery, 5841 South Maryland Avenue, MC 3079, Room J-611, The University of Chicago Medical Center, Chicago, Illinois 60637, USA.
J Orthop Res. 2007 May;25(5):665-77. doi: 10.1002/jor.20359.
Efficacious bone regeneration could revolutionize the clinical management of many bone and musculoskeletal disorders. Bone morphogenetic proteins (BMPs) can regulate the differentiation of mesenchymal stem cells into cartilage, bone, tendon/ligament, and fat lineages. Early data documented the osteogenic potential of rhBMP2 and rhBMP7/OP-1. However, prior to this work that summarized several of our recent studies, no comprehensive analysis had been undertaken to characterize relative osteogenic activity of all BMPs. Using recombinant adenoviruses expressing 14 BMPs, we have demonstrated that, besides BMP2 and BMP7, BMP6 and BMP9 exhibit the highest osteogenic activity both in vitro and in vivo. We further demonstrated that several BMPs may exert synergistic effect on osteogenic differentiation, and that osteogenic BMPs produce a distinct set of molecular fingerprints during osteogenic differentiation. The reported work should expand our current understanding of BMP functions during osteogenic differentiation. It is conceivable that osteogenic BMPs (i.e., BMP2, 4, 6, 7, and 9) may be used to formulate synergistic pairs among themselves and/or with other less osteogenic BMPs for efficacious bone regeneration in clinical settings.
有效的骨再生可能会彻底改变许多骨和肌肉骨骼疾病的临床治疗。骨形态发生蛋白(BMPs)可以调节间充质干细胞向软骨、骨、肌腱/韧带和脂肪谱系的分化。早期数据记录了重组人骨形态发生蛋白2(rhBMP2)和重组人骨形态发生蛋白7/OP-1的成骨潜力。然而,在这项总结我们近期多项研究的工作之前,尚未进行全面分析来表征所有BMPs的相对成骨活性。利用表达14种BMPs的重组腺病毒,我们已经证明,除了BMP2和BMP7之外,BMP6和BMP9在体外和体内均表现出最高的成骨活性。我们进一步证明,几种BMPs可能对成骨分化发挥协同作用,并且成骨BMPs在成骨分化过程中产生一组独特的分子指纹。所报道的工作应该会扩展我们目前对成骨分化过程中BMP功能的理解。可以想象,成骨BMPs(即BMP2、4、6、7和9)可能用于在它们自身之间和/或与其他成骨能力较弱的BMPs形成协同组合,以在临床环境中实现有效的骨再生。